1. Volume 17, Issue 2, Pages 223-230 (March 2014)
Cost-Effectiveness of Statins for Primary Prevention in Patients Newly Diagnosed with Type 2 Diabetes in The Netherlands 
Folgerdiena M. de Vries, BSc, Petra Denig, PhD, Sipke T. Visser, MSc, Eelko Hak, PhD, Maarten J. Postma, PhD 
Value in Health 
Volume 17, Issue 2, Pages (March 2014)
DOI: /j.jval
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1 Markov model. CHD, coronary heart disease.
Value in Health  , DOI: ( /j.jval )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2
Tornado diagram; all parameters are increased and decreased with 25%. CHD, coronary heart disease.
Value in Health  , DOI: ( /j.jval )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

4. Fig. 3
Cost-effectiveness acceptability curves from the probabilistic sensitivity analysis.
Value in Health  , DOI: ( /j.jval )
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions